{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:13:33Z","timestamp":1777425213540,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"NIDA","doi-asserted-by":"publisher","award":["DA 06634"],"award-info":[{"award-number":["DA 06634"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"NIDA","doi-asserted-by":"publisher","award":["DA 12970"],"award-info":[{"award-number":["DA 12970"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.neuroscience.2016.03.002","type":"journal-article","created":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T12:45:32Z","timestamp":1457354732000},"page":"367-376","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Attenuation of cocaine self-administration by chronic oral phendimetrazine in rhesus monkeys"],"prefix":"10.1016","volume":"324","author":[{"given":"P.W.","family":"Czoty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.E.","family":"Blough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.R.","family":"Fennell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.W.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Nader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2016.03.002_b0005","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S0376-8716(03)00099-1","article-title":"Principles of drug abuse liability assessment in laboratory animals","volume":"5","author":"Ator","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0010","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1038\/npp.2013.180","article-title":"Effects of phendimetrazine treatment on cocaine vs. food choice and extended-access cocaine consumption in rhesus monkeys","volume":"38","author":"Banks","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0015","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2012.10.026","article-title":"Role of phenmetrazine as an active metabolite of phendimetrazine: evidence from studies of drug discrimination and pharmacokinetics in rhesus monkeys","volume":"130","author":"Banks","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0020","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.drugalcdep.2013.05.005","article-title":"Effects of 14-day treatment with the schedule III anorectic phendimetrazine on choice between cocaine and food in rhesus monkeys","volume":"131","author":"Banks","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0025","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/npp.2012.193","article-title":"Interaction between behavioral and pharmacological treatment strategies to decrease cocaine choice in rhesus monkeys","volume":"38","author":"Banks","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0030","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/FBP.0b013e32834d63ac","article-title":"Effects of monoamine releasers with varying selectivity for releasing dopamine\/norepinephrine versus serotonin on choice between cocaine and food in rhesus monkeys","volume":"22","author":"Banks","year":"2011","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0035","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv009","article-title":"Preclinical assessment of lisdexamfetamine as an agonist medication candidate for cocaine addiction: effects in rhesus monkeys trained to discriminate cocaine or self-administer cocaine in a cocaine versus food choice procedure","volume":"18","author":"Banks","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0040","first-page":"1114","article-title":"Evaluation of phendimetrazine bitartarate as an appetite suppressant","volume":"84","author":"Cass","year":"1961","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0045","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-008-1222-8","article-title":"Cocaine self-administration reinforced on a progressive ratio schedule decreases with continuous D-amphetamine treatment in rats","volume":"200","author":"Chiodo","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0050","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00213-009-1622-4","article-title":"Decreased reinforcing effects of cocaine following 2 weeks of continuous d-amphetamine treatment in rats","volume":"206","author":"Chiodo","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0055","first-page":"351","article-title":"Anorectics: effects on food intake and self-administration in rhesus monkeys","volume":"7","author":"Corwin","year":"1987","journal-title":"Alcohol Drug Res"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0060","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/npp.2010.185","article-title":"Prolonged attenuation of the reinforcing strength of cocaine by chronic d-amphetamine in rhesus monkeys","volume":"36","author":"Czoty","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0065","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00213-010-1807-x","article-title":"Effects of chronic d-amphetamine on the reinforcing strength of cocaine in rhesus monkeys","volume":"209","author":"Czoty","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0070","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1124\/jpet.113.204321","article-title":"Effects of chronic methylphenidate on cocaine self-administration under a progressive-ratio schedule of reinforcement in rhesus monkeys","volume":"345","author":"Czoty","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2016.03.002_b9000","unstructured":"Czoty PW, Stoops WW, Rush CR (in press) Evaluation of the pipeline for development of medications for cocaine use disorder: a review of translational animal laboratory, human laboratory and clinical trial research. Pharmacol Rev."},{"key":"10.1016\/j.neuroscience.2016.03.002_b0075","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1007\/s00213-015-3875-4","article-title":"Effects of the norepinephrine releaser phenmetrazine on cocaine self-administration and cocaine-primed reinstatement in rats","volume":"232","author":"Czoty","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0080","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1530-0277.2010.01290.x","article-title":"Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials","volume":"34","author":"Falk","year":"2010","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0085","unstructured":"FDA (2015) Alcoholism: Developing drugs for treatment. Available at: http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm433618.pdf. Accessed 10 September 2015."},{"key":"10.1016\/j.neuroscience.2016.03.002_b0090","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1124\/jpet.111.185538","article-title":"Effects of varenicline on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys","volume":"339","author":"Gould","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0095","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00004714-200110000-00010","article-title":"Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial","volume":"21","author":"Grabowski","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0100","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.addbeh.2004.06.018","article-title":"Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence","volume":"29","author":"Grabowski","year":"2004","journal-title":"Addict Behav"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0105","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.npp.1300392","article-title":"Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials","volume":"29","author":"Grabowski","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0110","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11920-013-0415-y","article-title":"Pharmacotherapy for stimulant-related disorders","volume":"15","author":"Haile","year":"2013","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0115","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00213-008-1079-x","article-title":"Controversies in translational research: drug self-administration","volume":"199","author":"Haney","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0120","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.neuropharm.2013.05.021","article-title":"A preclinical evaluation of the discriminative and reinforcing properties of lisdexamfetamine in comparison to D-amfetamine, methylphenidate and modafinil","volume":"73","author":"Heal","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0125","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1749-6632.2009.05145.x","article-title":"Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies","volume":"1187","author":"Herin","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0130","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1124\/pr.110.003459","article-title":"Prodrugs\u2014from serendipity to rational design","volume":"63","author":"Huttune","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0135","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/00952997909007032","article-title":"Frequency of use or abuse of amphetamine-related drugs","volume":"6","author":"Jain","year":"1979","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0140","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/15563650.2015.1027903","article-title":"Comparison of lisdexamfetamine and dextroamphetamine exposures reported to U.S. poison centers","volume":"53","author":"Kaland","year":"2015","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0145","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1185\/030079908X280707","article-title":"A qualitative review of issues arising in the use of psychostimulant medications in patients with ADHD and co-morbid substance abuse disorders","volume":"24","author":"Kollins","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0150","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/jamapsychiatry.2015.41","article-title":"Extended-release mixed amphetamine salts vs placebo for comorbid adult attention-deficit\/hyperactivity disorder and cocaine use disorder: a randomized clinical trial","volume":"72","author":"Levin","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0155","doi-asserted-by":"crossref","DOI":"10.1007\/s40501-015-0038-5","article-title":"Outcome measures in medication trials for substance use disorders","author":"McCann","year":"2015","journal-title":"Curr Treat Options Psychiatry"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0160","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0893-133X(95)00274-H","article-title":"Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures","volume":"14","author":"Mello","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2008.10.016","article-title":"Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial","volume":"101","author":"Mooney","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0170","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.drugalcdep.2015.05.042","article-title":"Pilot study of the effects of lisdexamfetamine on cocaine use: a randomized, double-blind, placebo-controlled trial","volume":"153","author":"Mooney","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0175","first-page":"909","article-title":"Rapid assessment of choice between cocaine and food in rhesus monkeys: effects of environmental manipulations and treatment with d-amphetamine and flupenthixol","volume":"28","author":"Negus","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0180","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1124\/jpet.108.143701","article-title":"Selective suppression of cocaine- versus food-maintained responding by monoamine releasers in rhesus monkeys: benzylpiperazine, (+)phenmetrazine, and 4-benzylpiperidine","volume":"329","author":"Negus","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0185","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1038\/npp.2014.322","article-title":"Agonist medications for the treatment of cocaine use disorder","volume":"40","author":"Negus","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0190","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00213-003-1409-y","article-title":"Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a progressive-ratio schedule in rhesus monkeys","volume":"167","author":"Negus","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0376-8716(02)00339-3","article-title":"Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys","volume":"70","author":"Negus","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0200","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/NDT.S9749","article-title":"Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine","volume":"6","author":"Pennick","year":"2010","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0270(95)00153-0","article-title":"Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy","volume":"66","author":"Richardson","year":"1996","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-2999(02)01830-7","article-title":"Interaction of the anorectic medication, phendimetrazine, and its metabolites with monoamine transporters in rat brain","volume":"447","author":"Rothman","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0215","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4155\/fmc.11.184","article-title":"Agonist replacement therapy for cocaine dependence: a translational review","volume":"4","author":"Rush","year":"2012","journal-title":"Future Med Chem"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0220","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1360-0443.2003.00447.x","article-title":"Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence","volume":"98","author":"Shearer","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0225","doi-asserted-by":"crossref","unstructured":"Stoops WW, Bolin BL, Sites JP, Rush CR (2015) Abuse potential of oral phendimetrazine in cocaine-dependent individuals. College on Problems of Drug Dependence 77th Annual Meeting Abstracts, 152.","DOI":"10.1016\/j.drugalcdep.2015.07.574"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0230","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/jeab.15","article-title":"Cocaine versus food choice procedure in rats: environmental manipulations and effects of amphetamine","volume":"99","author":"Thomsen","year":"2013","journal-title":"J Exp Anal Behav"},{"key":"10.1016\/j.neuroscience.2016.03.002_b0235","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1755-5949.2011.00288.x","article-title":"Reanalysis of methamphetamine dependence treatment trial","volume":"18","author":"Winchell","year":"2012","journal-title":"CNS Neurosci Ther"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452216002244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452216002244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T16:42:37Z","timestamp":1572367357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452216002244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":48,"alternative-id":["S0306452216002244"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2016.03.002","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}